Exscientia one of three finalists for Best Emerging UK Biotech Company at the OBN awards.

Escientia were one of the three finalists for “Best Emerging UK Biotech Company” at the OBN awards ceremony, held at the Ashmolean Museum in Oxford on 1st October. This is the fourth biotech award that ex scientia have been finalists for in 12 months and recognises the impact the company is having on the UK biotech sector.

OBN is a UK organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. The event emphasised the breadth and depth of innovation coming from groups over the UK.